News
Delivering Chemotherapy Directly to Tumors
New grant explores precision drug delivery in NETs The American Association of Cancer Researchers (AACR) has awarded a NETRF-funded research grant to a Texas researcher
Coping with the Uncertainty of Cancer
Coping with the uncertainty of a cancer diagnosis means finding ways to take your mind off cancer, to do what you enjoy most, finding meaning and purpose.
Travel Tips for Cancer Patients
Neuroendocrine cancer patients traveling for pleasure, business, or cancer treatment, may need to consider a few extra details to ensure travel goes smoothly. These travel
Finding May Help Predict Pancreatic NET Recurrence
NETRF-funded researchers identified a cancer cell type that is associated with non-functional pancreatic neuroendocrine tumor (pNET) recurrence. Alpha-like pNET cell expression of the protein ARX can guide prognosis.
Grant Applications Go to Board of Scientific Advisors
NETRF’s Board of Scientific Advisors and external reviewers will begin reading and ranking the 2019 requests for research funding. Wide Range of Requests for NET
NETRF Welcomes John Kanki, PhD, as New Research Director
John Kanki, PhD, has joined Neuroendocrine Tumor Research Foundation (NETRF) as Director of Research. In this position, Dr. Kanki will oversee the strategic, scientific, and
In Memory of Carol Branaman
Neuroendocrine cancer community faces loss. Carol Branaman, vice chair and former chair of NETRF, passes from neuroendocrine cancer.
Rocks that Bring Hope
From a place of discouragement after being diagnosed with a NET in June 2018, Susan Garrett of Roxboro, NC, saw a news story on WRAL
Exploring a New Targeted Therapy
UCSF Shares Promising Results of a Clinical Trial At the 2019 meeting of the American Cancer Society of Clinical Oncologists (ASCO), Emily Bergsland, MD, University
FAQs Neuroendocrine Tumor Tissue Donation
The need for tumor tissue in NETs The Neuroendocrine Tumor Research Foundation is on a mission to fill the urgent need for more neuroendocrine tumor